Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cytomegalovirus Infection
100%
Solid Organ Transplant Recipients
100%
Ganciclovir
100%
Combination Antiviral Therapy
100%
Ganciclovir-resistant
100%
Cytomegalovirus
66%
Foscarnet
66%
Therapeutic Agents
33%
Increased Dose
33%
Clinical Significance
33%
Disease Progression
33%
Solid Organ Transplantation
33%
Daily Dose
33%
Dosing Regimen
33%
Persistent Infection
33%
Organ Transplant Recipients
33%
Therapeutic Failure
33%
Magnesium Depletion
33%
Half-dose
33%
Failure Progression
33%
Medicine and Dentistry
Cytomegalovirus Infection
100%
Antiviral Therapy
100%
Ganciclovir
100%
Cytomegalovirus
33%
Foscarnet
33%
Clinical Significance
16%
Disease Exacerbation
16%
Solid Organ Transplantation
16%
Drug Dose Regimen
16%
Persistent Infection
16%
Magnesium Depletion
16%
Pharmacology, Toxicology and Pharmaceutical Science
Antiviral Therapy
100%
Cytomegalovirus Infection
100%
Ganciclovir
100%
Foscarnet
33%
Cytomegalovirus
33%
Disease Exacerbation
16%
Persistent Infection
16%
Immunology and Microbiology
Cytomegalovirus Infection
100%
Cytomegalovirus
100%
Drug Dose Regimen
50%
Solid Organ Transplantation
50%
Infection
50%